Filing Details

Accession Number:
0001179110-18-013511
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-06 16:02:22
Reporting Period:
2018-12-03
Accepted Time:
2018-12-06 16:02:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1650664 Editas Medicine Inc. EDIT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1592469 Katrine Bosley C/O Editas Medicine, Inc.
11 Hurley St.
Cambridge MA 02141
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-03 11,900 $31.92 1,217,066 No 4 S Direct
Common Stock Disposition 2018-12-03 100 $32.39 1,216,966 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 17, 2017, as amended.
  2. This transaction was executed in multiple trades at prices ranging from $31.36 to $32.28. The price reported above reflected the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.